Following the posting of this activity tirzepatide has received FDA approval for use in adults with obesity (with a BMI of 30 kg/m2 or greater), or those who are overweight (with a BMI of 27 kg/m2 or greater) and also have weight-related medical problems such as hypertension, dyslipidemia, type 2 diabetes mellitus, obstructive sleep apnea or cardiovascular disease, to lose weight and keep it off. It should be used with a reduced-calorie diet and increased physical activity.
PROGRAM CHAIR & FACULTY PRESENTER
Fatima Cody Stanford, MD, MPH, MPA, MBA, FAAP, FACP, FAHA, FAMWA, FTOS
Associate Professor of Medicine and Pediatrics, Harvard Medical School
Obesity Medicine Physician Scientist, Massachusetts General Hospital
Diplomate American Board of Obesity Medicine
Director of Diversity, Nutrition Obesity Research Center at Harvard (NORCH)
Director of Equity, Massachusetts General Hospital, Endocrine Division
Boston, MA
PROGRAM OVERVIEW
This enduring activity provides a comprehensive overview of the chronic disease of obesity and opportunities to improve the quality of care in the primary care setting. It incorporates a variety of interactive tools, including animations and case studies, to create a dynamic learning experience.
TARGET AUDIENCE
This educational activity is intended for U.S.-based PCPs, PAs, and NPs who treat people with obesity.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Evaluate the physiological pathways that defend against weight loss and promote weight regain
- Select diagnostic and therapeutic strategies for patients with obesity based on guidelines and clinical evidence
- Assess the safety, efficacy and mechanisms of available and emerging antiobesity medications
- Implement shared decision making and motivational communications strategies in discussions with patients about obesity
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
JOINT ACCREDITATION STATEMENT
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Med Learning Group. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
NURSES (ANCC) CREDIT DESIGNATION
Amedco LLC designates this activity for a maximum of 1.0 ANCC contact hour.
COMMISION ON DIETETIC REGISTRATION
This program has received prior approval with the Commission on Dietetic Registration for dietitians and RDs.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIP(S)
Faculty Member | Disclosures |
Fatima Cody Stanford, MD, MPH, MPA | Consultant fees: Boehringer Ingelheim, Calibrate, Clearmind, Currax, Doximity, Gelesis, GoodRX, Ilant Health, Lifeforce, Lilly, MelliCell, Novo Nordisk, Pfizer, Rhythm, Sweetch, Verifarma, and Vida Health. |
All relevant financial relationships have been mitigated.
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
CNE Content Review
The content of this activity was peer reviewed by a nurse reviewer.
The reviewer of this activity has nothing to disclose.
Staff Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME/CE activity:
- Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
- Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
- Deb Gordon, Medical Director for Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
- Jessica McMullen, MPH, Program Manager for Med Learning Group, has nothing to disclose.
- Laura Aibara, Program Coordinator for Med Learning Group, has nothing to disclose.
- Aimee Meissner, Accreditation and Outcomes Coordinator, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity.
In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation.
Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at https://www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
RELEASED DATE: August 07, 2023
EXPIRATION DATE: August 07, 2024
FACULTY
Fatima Cody Stanford, MD, MPH, MPA, MBA, FAAP, FACP, FAHA, FAMWA, FTOS
Associate Professor of Medicine and Pediatrics, Harvard Medical School
Obesity Medicine Physician Scientist, Massachusetts General Hospital
Diplomate American Board of Obesity Medicine
Director of Diversity, Nutrition Obesity Research Center at Harvard (NORCH)
Director of Equity, Massachusetts General Hospital, Endocrine Division
Boston, MA
FEATURING
Candy Jewett
Waltham, MA
PROGRAM OVERVIEW
This enduring activity is designed to help US-based healthcare professionals understand obesity from the patient perspective, recognize the physiological underpinnings of obesity, and use evidence-based strategies for the diagnosis, treatment, and management of people with obesity. It uses a unique documentary approach to share a patient story along with commentary from an expert in obesity medicine.
TARGET AUDIENCE
This educational activity is intended for U.S. PCPs, PAs, and NPs who treat people with obesity.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Select diagnostic and therapeutic strategies for patients with obesity based on guidelines and clinical evidence
- Assess the safety, efficacy and mechanisms of available and emerging antiobesity medications
- Implement shared decision making and motivational communications strategies in discussions with patients about obesity
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 0.50 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring.
CONTINUING EDUCATION LANGUAGE
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Med Learning Group. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses (ANCC) Credit Designation
Amedco LLC designates this activity for a maximum of 0.50 ANCC contact hour.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
Fatima Cody Stanford, MD | Consultant fees: Boehringer Ingelheim, Calibrate, Clearmind, Currax, Doximity, Gelesis, GoodRX, Ilant Health, Lifeforce, Lilly, MelliCell, Novo Nordisk, Pfizer, Rhythm, Sweetch, Verifarma, and Vida Health. |
Candy Jewett | Has nothing to disclose |
All relevant financial relationships have been mitigated.
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
CNE Content Review
The content of this activity was peer reviewed by a nurse reviewer.
The reviewer of this activity has nothing to disclose.
Staff Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME/CE activity:
- Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
- Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
- Deb Gordon, Medical Director for Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
- Marissa Mays-Verman, Program Manager for Med Learning Group, has nothing to disclose.
- Alexis Klinger, Program Coordinator for Med Learning Group, has nothing to disclose.
- Aimee Meissner, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at https://www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
RELEASED DATE: September 29, 2023
EXPIRATION DATE: September 29, 2024
FACULTY
Fatima Cody Stanford, MD, MPH, MPA, MBA, FAAP, FACP, FAHA, FAMWA, FTOS
Associate Professor of Medicine and Pediatrics, Harvard Medical School
Obesity Medicine Physician Scientist, Massachusetts General Hospital
Diplomate American Board of Obesity Medicine
Director of Diversity, Nutrition Obesity Research Center at Harvard (NORCH)
Director of Equity, Massachusetts General Hospital, Endocrine Division
Boston, MA
FEATURING
Daniela Romero
Wilbraham, MA
PROGRAM OVERVIEW
This enduring activity is designed to help US-based healthcare professionals understand obesity from the patient perspective, recognize the physiological underpinnings of obesity, and use evidence-based strategies for the diagnosis, treatment, and management of people with obesity. It uses a unique documentary approach to share a patient story along with commentary from an expert in obesity medicine.
TARGET AUDIENCE
This educational activity is intended for U.S. PCPs, PAs, and NPs who treat people with obesity.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Evaluate the physiological pathways that defend against weight loss and promote weight regain
- Select diagnostic and therapeutic strategies for patients with obesity based on guidelines and clinical evidence
- Assess the safety, efficacy and mechanisms of available and emerging antiobesity medications
- Implement shared decision making and motivational communications strategies in discussions with patients about obesity
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 0.50 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
CONTINUING EDUCATION LANGUAGE
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Med Learning Group. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses (ANCC) Credit Designation
Amedco LLC designates this activity for a maximum of 0.50 ANCC contact hour.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
Fatima Cody Stanford, MD | Consultant fees: Boehringer Ingelheim, Calibrate, Clearmind, Currax, Doximity, Gelesis, GoodRX, Ilant Health, Lifeforce, Lilly, MelliCell, Novo Nordisk, Pfizer, Rhythm, Sweetch, Verifarma, and Vida Health. |
Daniela Romero | Has nothing to disclose |
All relevant financial relationships have been mitigated.
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
CNE Content Review
The content of this activity was peer reviewed by a nurse reviewer.
The reviewer of this activity has nothing to disclose.
Staff Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME/CE activity:
- Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
- Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
- Deb Gordon, Medical Director for Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
- Marissa Mays-Verman, Program Manager for Med Learning Group, has nothing to disclose.
- Alexis Klinger, Program Coordinator for Med Learning Group, has nothing to disclose.
- Aimee Meissner, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at https://www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
RELEASED DATE: September 29, 2023
EXPIRATION DATE: September 29, 2024
FACULTY
Caroline Apovian, MD
Co-Director, Center for Weight Management and Wellness
Brigham and Women’s Hospital
Professor of Medicine, Harvard Medical School
Boston, MA
FEATURING
Charleah Torres-Vega
Hyde Park, MA
PROGRAM OVERVIEW
This enduring activity is designed to help US-based healthcare professionals understand obesity from the patient perspective, recognize the physiological underpinnings of obesity, and use evidence-based strategies for the diagnosis, treatment, and management of people with obesity. It uses a unique documentary approach to share a patient story along with commentary from an expert in obesity medicine.
TARGET AUDIENCE
This educational activity is intended for U.S. PCPs, PAs, and NPs who treat people with obesity.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Evaluate the physiological pathways that defend against weight loss and promote weight regain
- Implement shared decision making and motivational communications strategies in discussions with patients about obesity
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 0.50 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring.
CONTINUING EDUCATION LANGUAGE
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Med Learning Group. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses (ANCC) Credit Designation
Amedco LLC designates this activity for a maximum of 0.50 ANCC contact hour.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
Caroline Apovian, MD | Discloses that she has received consulting fees from Altimmune, Cowen and Company, Currax, EPG Communication Holdings, Form Health, Gelesis, L-Nutra, NeuroBo, Novo Nordisk, PainScript, Pursuit By You, ReShape Lifesciences, Riverview School, and Xeno Biosciences. |
Charleah Torres-Vega | Has nothing to disclose |
All relevant financial relationships have been mitigated.
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
CNE Content Review
The content of this activity was peer reviewed by a nurse reviewer.
The reviewer of this activity has nothing to disclose.
Staff Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME/CE activity:
- Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
- Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
- Deb Gordon, Medical Director for Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
- Marissa Mays-Verman, Program Manager for Med Learning Group, has nothing to disclose.
- Alexis Klinger, Program Coordinator for Med Learning Group, has nothing to disclose.
- Aimee Meissner, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at https://www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
RELEASED DATE: September 29, 2023
EXPIRATION DATE: September 29, 2024
PROGRAM CHAIRS
Karlijn Burridge, PA-C, MMS, FOMA
President, PAs in Obesity Medicine
Owner, Gaining Health
Host, Gaining Health Podcast
Obesity Specialist PA, Ascension Weight Loss Solutions
Westmont, IL
Chuck Vega, MD, FAAFP
Clinical Professor
UC Irvine Department of Family Medicine
Assistant Dean for Culture and Community Education
Director, UC Irvine Program in Medical Education for the Latino Community
UC Irvine
Irvine, CA
SPEAKING FACULTY
Neil Skolnik, MD
Professor of Family and Community Medicine
Sidney Kimmel Medical College
Thomas Jefferson University
Abington, PA
PROGRAM OVERVIEW
This enduring activity is designed to help US-based healthcare professionals recognize the physiological underpinnings of obesity and use evidence-based strategies for the diagnosis, treatment, and management of people with obesity. Along with didactic instruction, this activity will include case studies with Q&A to provide practice identifying patients who would benefit from obesity diagnosis and treatment, ultimately improving outcomes of patients affected by this complex, chronic disease.
TARGET AUDIENCE
This educational activity is intended for US-based primary care physicians, physician assistants, and nurse practitioners who treat people with obesity.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Evaluate the physiological pathways that defend against weight loss and promote weight regain
- Select diagnostic and therapeutic strategies for patients with obesity based on guidelines and clinical evidence
- Assess the safety, efficacy and mechanisms of available and emerging antiobesity medications
- Implement shared decision making and motivational communications strategies in discussions with patients about obesity
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 1.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
JOINT ACCREDITATION STATEMENT
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Med Learning Group. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
NURSES (ANCC) CREDIT DESIGNATION
Amedco LLC designates this activity for a maximum of 1.25 ANCC contact hours.
COMMISION ON DIETETIC REGISTRATION
This program has received prior approval with the Commission on Dietetic Registration for dietitians and RDs.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
Karlijn Burridge, PA-C, MMS, FOMA | She has received consulting fees from Novo Nordisk, Vivus, and Lilly. She was part of a speaker’s bureau for Vivus. She is also the owner of Gaining Health. |
Charles Vega, MD | Has nothing to disclose. |
Neil Skolnik, MD | He has received consulting fees from and participated on advisory boards for AstraZeneca, Teva, Lilly, Boehringer Ingelheim, Sanofi, Sanofi Pasteur, GSK, Bayer, Genentech, Abbot, Idorsia, Novartis, Novo Nordisk, and Astellas. He was part of a speaker’s bureau for AstraZeneca, Boehringer Ingelheim, Lilly, GSK, Teva, Bayer, Heartland, and Astellas; and did contracted research for Sanofi, AstraZeneca, GSK, Bayer, and Novo Nordisk. |
All relevant financial relationships have been mitigated.
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
CNE Content Review
The content of this activity was peer reviewed by a nurse reviewer.
The reviewer of this activity has nothing to disclose.
Staff Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME/CE activity:
- Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
- Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
- Cindy Lampner, MSLIS, Medical Director for Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
- Marissa Mays-Verman, Senior Program Manager for Med Learning Group, has nothing to disclose.
- Alexis Klinger, Associate Program Manager for Med Learning Group, has nothing to disclose.
- Aimee Meissner, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at https://www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
RELEASED DATE: October 31, 2023
EXPIRATION DATE: October 31, 2024
Copyright © 2023 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.